Mild therapeutic hypothermia (MTH) results in a significant decrease in mortality and improvement of neurologic outcomes in cardiac arrest (CA) survivors. Cardiologists and intensivists must be acquainted with the indications and technique because MTH is the only proven neuroprotective therapy for CA survivors. CA involves reinstituting meaningful cardiac activity and minimizing secondary neurologic injuries. This article focuses on MTH as the main strategy for post-CA care.
Keywords: Cardiac arrest survivors; Hypoxic-ischemic brain injury; Mild therapeutic hypothermia; Neurologic prognosis.
Copyright © 2013 Elsevier Inc. All rights reserved.